| P2093 | author name string | S Lemoine | |
| | J-L Gérard | |
| | J-L Hanouz | |
| | S Allouche | |
| | X Valette | |
| P2860 | cites work | Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload | Q28568167 |
| | Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase | Q28577236 |
| | Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 |
| | Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis | Q36392617 |
| | Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides | Q36473624 |
| | Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema | Q36516029 |
| | Identification of cardiac dysfunction in sepsis with B-type natriuretic peptide | Q37868148 |
| | Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta. | Q42389664 |
| | Plasma NT-proBNP increases in response to LPS administration in healthy men. | Q43435166 |
| | Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis | Q43707142 |
| | Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes | Q44021117 |
| | National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure | Q48105140 |
| | Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock | Q48255307 |
| | Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in vivo and in vitro | Q48447517 |
| | Impaired plasma B-type natriuretic peptide clearance in human septic shock | Q49012575 |
| | In vitro effects of desflurane, sevoflurane, isoflurane, and halothane in isolated human right atria. | Q51422484 |
| | Positive end-expiratory pressure ventilation decreases plasma atrial and brain natriuretic peptide levels in humans. | Q51649108 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipopolysaccharide | Q421804 |
| P304 | page(s) | 860-865 | |
| P577 | publication date | 2012-04-04 | |
| P1433 | published in | Acta Anaesthesiologica Scandinavica | Q59829 |
| P1476 | title | Effect of lipopolysaccharide, cytokines, and catecholamines on brain natriuretic peptide release from human myocardium | |
| P478 | volume | 56 | |